Mengting liu | Cell Structure Analysis | Best Researcher Award

Posted on by Cell Biologist

Assoc. Prof. Dr. Mengting liu | Cell Structure Analysis | Best Researcher Award

Assoc. Prof. Dr. Mengting liu, Xi’an Jiaotong University, China

Dr. Mengting Liu is an Associate Professor and Master’s Supervisor at the School of Electrical Engineering, Xi’an Jiaotong University. A promising scholar in advanced battery materials, she has made significant contributions to lithium-sulfur, sodium-ion, and zinc-based battery technologies. Dr. Liu holds a Ph.D. in Condensed Matter Physics from Lanzhou University and completed joint doctoral training at the Georgia Institute of Technology, under the mentorship of Prof. Gleb Yushin. As the principal investigator of several high-profile national projects, her work centers around electrolyte design, interfacial chemistry, and cathode material innovation. Dr. Liu has authored over 50 SCI papers in top-tier journals and holds more than 30 patents, reflecting her innovative contributions to electrochemical energy storage. With an H-index of 24 and successful technological transformations, she stands out as a leading young researcher shaping the future of sustainable energy materials in China and globally.

Publication Profile: 

scopus

✅ Strengths for the Award:

  1. High-Impact Publications

    • Over 50 SCI-indexed papers in world-renowned journals such as J. Am. Chem. Soc., Advanced Materials, Energy & Environmental Science, and Nano Energy.

    • Numerous first-author and corresponding-author contributions, showcasing leadership in research.

  2. Innovation in Battery Technology

    • Pioneer in sodium-ion, lithium-sulfur, and zinc-ion battery materials, particularly focusing on interfacial engineering and electrolyte design.

    • Leads cutting-edge research in cold-environment batteries and high-voltage cathodes.

  3. Recognition and Funding

    • Principal Investigator of multiple National Natural Science Foundation of China (NSFC) projects.

    • Successfully translated 3 technologies into industrial application – indicating practical impact.

  4. Patent and Intellectual Property

    • 30+ patents applied/granted, reflecting a commitment to innovation and intellectual property creation.

  5. Academic Metrics

    • H-index: 24, indicating solid citation impact and relevance in the field.

  6. International Exposure

    • Conducted joint Ph.D. research at Georgia Institute of Technology, under the mentorship of global battery expert Prof. Gleb Yushin.

  7. Mentorship and Leadership

    • Serves as Master’s Supervisor, contributing to the training of the next generation of researchers.

🔧 Areas for Improvement:

  1. Public and Global Recognition

    • While the academic output is outstanding, broader international visibility (e.g., keynote speeches, global consortia participation) could strengthen recognition.

  2. Cross-disciplinary Expansion

    • Exploring AI-driven materials discovery or solid-state battery systems could further diversify her portfolio and enhance future relevance.

  3. Team Expansion and Postdoctoral Supervision

    • Expanding mentorship to include postdoctoral researchers and international collaborators could amplify research output and impact.

📚 Education:

Dr. Mengting Liu earned her Ph.D. in Condensed Matter Physics from Lanzhou University (2015–2021), focusing on electrochemical materials and battery interface design. During her doctoral studies, she was awarded a prestigious national scholarship for joint training at the Georgia Institute of Technology (2018–2020), where she conducted cutting-edge research in the School of Materials Science and Engineering under Prof. Gleb Yushin. Her work there focused on advanced cathode materials for sodium-ion and lithium-sulfur batteries, combining material design, characterization, and performance optimization. Her academic foundation is grounded in interdisciplinary training, bridging physics, chemistry, and materials science. Her research was pivotal in understanding phase transitions, solid–electrolyte interfaces, and novel electrolyte systems, which has set the stage for her postdoctoral and faculty research directions in energy storage. Her academic path reflects a strong alignment with innovation in clean energy technologies and fundamental materials science.

🧪 Experience:

Since November 2021, Dr. Mengting Liu has served as an Assistant Professor (Qingxiao Program A) at Xi’an Jiaotong University’s School of Electrical Engineering. She is actively involved in supervising graduate students and leading independent research in electrochemical energy storage. Prior to this role, she spent over two years at the Georgia Institute of Technology during her doctoral studies, collaborating with international experts and engaging in high-impact research. She has led several major research projects funded by the National Natural Science Foundation of China, focusing on electrolyte structure regulation and cathode performance optimization. Her industrial collaborations have led to three technological transformations and over 30 patents. Dr. Liu’s interdisciplinary background and international exposure have enabled her to contribute extensively to frontier research in lithium-ion, lithium-sulfur, and sodium-ion battery technologies. Her teaching and mentoring roles complement her research, contributing to talent development in the energy storage field.

🔬 Research Focus:

Dr. Mengting Liu’s research is centered on electrochemical energy storage, with a particular focus on sodium-ion, lithium-sulfur, and lithium-ion batteries. Her work involves the design of high-performance cathode materials, such as layered oxides and composite structures, and the development of nonflammable, stable electrolytes that enable long-life and high-temperature battery operation. She is especially recognized for her studies on interfacial engineering, including cathode-electrolyte interphases (CEI) and solid electrolyte interphases (SEI), which are critical to battery safety and longevity. Her recent research expands into entropy-regulated materials and polymer electrolytes to tackle extreme environmental conditions like ultra-low temperatures. With a holistic approach combining material synthesis, mechanism analysis, and performance validation, Dr. Liu aims to develop next-generation batteries with high energy density, long cycle life, and environmental adaptability. Her research is not only academically impactful but also industrially relevant, bridging fundamental science with practical innovation.

📄 Publication Top Notes: 

  1. 🧯 Cation−Anion Regulation in Flame-Retardant Electrolytes for Safe Na-Ion Batteries – J. Am. Chem. Soc. (2025)

  2. 🔥 Nonflammable Sulfone-Based Electrolytes for High-Temp LiNi0.5Mn1.5O4 – ACS Energy Lett. (2024)

  3. ❄️ Inorganic-Rich Interphases via Nonflammable Electrolytes for Low-Temp LiNi0.5Mn1.5O4 – Adv. Funct. Mater. (2024)

  4. ⚡ Tailoring Cathode–Electrolyte Interface for High-Power Lithium–Sulfur Batteries – Nano-Micro Lett. (2025)

  5. 🔋 Wadsley–Roth Structure Engineering for High-Power Li-Ion Batteries – Energy Environ. Sci. (2024)

  6. 🔄 Biphaseto-Monophase Transition in Na0.766+xLixNi0.33-xMn0.5Fe0.1Ti0.07O2 – Carbon Energy (2024)

  7. 🛡️ Zn-Ion Channels with Double-Network Layer for Stable Zinc Anodes – Energy Storage Mater. (2024)

  8. 🔗 In-Situ Polymerized Ether Gel Electrolyte for High-Voltage Li-Metal Batteries – Adv. Funct. Mater. (2024)

  9. 🔧 Reinforced Bimetal Oxide-Based PEO Electrolytes for Stable Interfaces – Adv. Funct. Mater. (2025)

  10. ♻️ Phase-Stable and Air-Stable O3-Type Entropy-Reinforced Na Cathodes – Nano Energy (2025)

🧾 Conclusion:

Dr. Mengting Liu is exceptionally well-qualified for the Best Researcher Award. Her track record reflects a rare blend of deep theoretical knowledge, experimental expertise, and real-world application in the fast-evolving field of energy storage.

With a robust publication portfolio, a leadership role in nationally-funded projects, multiple technological transformations, and strong international training, she has already demonstrated leadership and innovation that align perfectly with the purpose of the award.

Junfeng Zhang | Cancer Cell Biology | Best Researcher Award

Posted on by Cell Biologist

Assoc. Prof. Dr. Junfeng Zhang | Cancer Cell Biology | Best Researcher Award

Assoc. Prof. Dr. Junfeng Zhang, Anhui University of Science and Technology, China

Dr. Junfeng Zhang is an Associate Professor and Deputy Director of the Center for Medical Frontiers at the School of Medicine, Anhui University of Science and Technology. With a Ph.D. in biomedical sciences, he has emerged as a leading figure in nanomedicine and cancer theranostics. His work integrates nanotechnology, molecular imaging, and drug delivery systems, particularly focusing on intelligent nanoformulations for tumor targeting and integrated diagnostics and therapy. Dr. Zhang is an active member of multiple national medical committees and has contributed significantly to interdisciplinary research. His publications in prestigious journals like Advanced Materials, Small Methods, and Advanced Science reflect both scientific depth and translational potential. As a council and committee member of several medical and health associations, he actively promotes collaboration across academic and healthcare institutions. His dedication to innovation and public health positions him as a rising star in biomedical engineering and personalized cancer therapy.

Publication Profile: 

Orcid

✅ Strengths for the Award:

  1. High-Impact Research Contributions

    • Dr. Zhang has published in top-tier international journals such as Advanced Materials (IF: 32.086), Advanced Science (IF: 15.1), and Small Methods (IF: 15.367).

    • His work demonstrates interdisciplinary excellence—combining nanotechnology, oncology, and imaging science to address complex medical challenges.

  2. Innovative Scientific Focus

    • Focused on intelligent theranostic nanoformulations, his research targets both diagnostic imaging and cancer therapy in a single platform.

    • He has developed laser-free imaging systems, nucleus-targeted drug delivery platforms, and responsive nanosystems, which are highly relevant to personalized and precision medicine.

  3. Leadership & Recognition

    • Serves as the Deputy Director of the Center for Medical Frontiers, showing strategic leadership.

    • Holds multiple national-level committee memberships, indicating peer recognition and influence in the field of nuclear medicine, digital health, and environmental mutagen studies.

  4. Collaborative & Global Research Impact

    • Frequently collaborates with international researchers like Prof. Rui L. Reis.

    • Demonstrates versatility in both experimental and translational research, addressing real-world medical and toxicological issues.

  5. Consistent Productivity

    • Maintains a consistent and strong publication record as first/corresponding author over the past five years, with multi-disciplinary themes.

⚠️ Areas for Improvement:

  1. Commercialization & Patent Activity

    • While his work is scientifically advanced, there is limited visible emphasis on patent filings, technology transfer, or startup ventures. Increasing focus here would enhance his profile for innovation-based awards.

  2. International Outreach

    • Although involved in collaborations, more visibility in international scientific conferences, editorial boards, or global awards could further strengthen his candidacy on the world stage.

  3. Public Health Engagement

    • As his work is deeply relevant to cancer management, more visible contributions to community awareness, patient education, or policy advisory roles could broaden the societal impact of his research.

🎓 Education:

Dr. Junfeng Zhang earned his doctoral degree (Ph.D.) in biomedical sciences, with a specialization in nanomedicine and molecular diagnostics. While the specific university name is not listed, the rigorous research output suggests training from a high-caliber institution. His education integrated core principles of pharmacology, biomedical engineering, and cancer biology, allowing him to build a strong foundation in interdisciplinary medical research. During his academic career, he focused on translational research that merges engineering, imaging technologies, and clinical applications. Through his doctoral training, Dr. Zhang acquired advanced techniques in nanoparticle synthesis, fluorescence imaging, and drug delivery. His education paved the way for impactful research in photoacoustic imaging and intelligent targeted therapies. Dr. Zhang’s academic background equipped him to lead cutting-edge research projects that align with global challenges in oncology. He continues to leverage his academic foundation to mentor graduate students and drive innovation in healthcare technology development.

🧪 Experience:

Dr. Zhang currently serves as Associate Professor and Deputy Director of the Center for Medical Frontiers at the School of Medicine, Anhui University of Science and Technology. He holds prominent roles including Council Member of the Anhui Provincial Society of Environmental Mutagens and committee memberships in nuclear medicine and digital health bodies. With over five years of experience in biomedical research and teaching, he has led numerous research projects at the interface of nanomedicine, cancer biology, and imaging diagnostics. His international collaborations and editorial contributions signify global recognition. As a mentor, he guides students and young researchers in clinical translation of nano-based therapies. His leadership at the Center for Medical Frontiers emphasizes high-impact innovation, collaborative research culture, and practical solutions to oncological diseases. His diverse experience in academic, clinical, and committee roles demonstrates his comprehensive influence in shaping future medical technologies and public health strategies.

🔬 Research Focus:

Dr. Zhang’s research focuses on the development of intelligent theranostic nanoformulations aimed at achieving both diagnosis and treatment of tumors in a single platform. His work emphasizes dual-mode imaging systems (photoacoustic/fluorescence), targeted drug delivery, and biocompatible nanocarriers capable of bypassing biological barriers. One of his key innovations involves creating gold- and carbon-based nanomaterials for laser-free imaging and mitochondrial apoptosis induction. He is particularly interested in nucleus-targeted therapies, precision drug delivery, and responsive nanosystems that adjust to tumor microenvironments. He also studies the toxicological aspects of nanomedicines under various physiological conditions, including magnetic field exposure and metabolic pathway disruptions. His research bridges disciplines like pharmacology, materials science, and medical imaging, contributing to the personalized medicine movement. With a strong publication record in high-impact journals, his research focus reflects a commitment to translating laboratory innovations into clinical applications to improve cancer diagnosis, treatment precision, and therapeutic outcomes.

📚 Publications Top Notes:

  1. 🧬 A Multifunctional Photoacoustic/Fluorescence Dual-Mode-Imaging Gold-Based Theranostic Nanoformulation without External Laser Limitations – Advanced Materials, 2022

  2. 💊 An Efficient Carbon-Based Drug Delivery System for Cancer Therapy through the Nucleus Targeting and Mitochondria Mediated Apoptotic Pathway – Small Methods, 2021

  3. 🧠 Humanistic Health Management and Cancer: Associations of Psychology, Nutrition, and Exercise with Cancer Progression and Pathogenesis – Advanced Science, 2024

  4. 🌿 Preparation, Characterization, and Evaluation of the Antitumor Effect of Kaempferol Nanosuspensions – Drug Delivery and Translational Research, 2023

  5. 🐟 High Concentrations of Fluorescent Nanoprobes Delayed Oryzias Melastigma Embryo Hatching by Modulating Respiratory and Metabolic Pathways – VIEW, 2025

  6. 🧲 The Biokinetics and Toxicology of Fe₃O₄ Nanoparticles Influenced by Magnetic Field and Protein – Nano, 2022

🧾 Conclusion:

Dr. Junfeng Zhang is a highly suitable and deserving candidate for the Best Researcher Award. His cutting-edge work in nanomedicine, combined with consistent high-impact publications, academic leadership, and contributions to national scientific bodies, clearly mark him as a rising and influential scientist in the medical research community. With slight enhancements in technology translation and international public engagement, he holds potential to become a global leader in biomedical innovation.

Sibel Elif Gultekin | Stem Cell Research | Best Researcher Award

Posted on by Cell Biologist

Prof. Dr. Sibel Elif Gultekin | Stem Cell Research | Best Researcher Award

Prof. Dr. Sibel Elif Gultekin, Gazi University Faculty of Dentistry, Turkey

Prof. Dr. Sibel Elif Gültekin is a renowned academic and clinician in Oral Pathology and Periodontology at Gazi University Faculty of Dentistry, Türkiye. With over two decades of experience, she has significantly advanced molecular understanding of odontogenic tumors, HPV-induced oral lesions, and periodontal regeneration. Holding both DDS and Ph.D. degrees, she has led her department as Chair for 10 years and contributed globally as a visiting researcher and advisor. Her collaborations with institutions like the University of Cologne and UCSF reflect her international impact. She has published extensively in high-impact journals, authored books, and mentored numerous young researchers. Her dedication has been recognized through editorial appointments and professional society memberships. Prof. Gültekin’s translational research bridges pathology and clinical dentistry, making her a pioneer in the diagnosis and treatment of oral diseases.

Publication Profile: 

Orcid

✅ Strengths for the Award:

  1. Dual Specialization & Academic Leadership: Prof. Gültekin’s rare dual Ph.D. in Oral Pathology and Periodontology, along with her decade-long leadership as department chair, highlights deep academic and organizational expertise.

  2. High Research Output & Impact: With 96 publications, 50+ research projects, and citations exceeding 1300 (Google Scholar), her scholarly productivity and influence are clear. Her h-index across databases (14–17) confirms consistent academic contribution.

  3. Global Collaborations: Active collaborations with international centers like UCSF and University of Cologne underscore her role in global scientific advancement.

  4. Innovative Research Areas: She works at the forefront of molecular oncology, focusing on HPV-associated oral cancers, odontogenic tumors, and biomarkers like P16, VIM3, and PDCD4.

  5. Educational & Editorial Leadership: Served on scientific and editorial boards, symposiums, and advisory panels; she also authored 2 academic books and guided national congresses.

  6. Professional Societies: Active member of multiple esteemed societies (IAOP, ESP, EHNS, IADR), reflecting recognition in the international scientific community.

⚙️ Areas for Improvement:

  1. Clinical Translation Scaling: While her biomarker discoveries are notable, increasing efforts to lead translational clinical trials could accelerate therapeutic application.

  2. Policy Advocacy: Engaging more in international oral health policy or WHO-affiliated programs could amplify her impact beyond academia.

  3. Mentorship on Global Scale: Expanding formal international mentorship programs or fellowships could further cement her influence and legacy.

🎓 Education:

Prof. Dr. Sibel Elif Gültekin holds both DDS and Ph.D. degrees, specializing in Oral Pathology and Periodontology. She completed her undergraduate dental studies at Gazi University Faculty of Dentistry, where she later pursued her doctoral studies. Her academic training extended beyond Türkiye through international fellowships and research placements, including the prestigious Department of Medicine and Stomatology at the University of California San Francisco (UCSF) and the Institute for Pathology at the University of Cologne. Her educational journey is marked by an interdisciplinary approach, blending basic sciences and clinical applications. These robust academic foundations have positioned her as a global expert in oral cancer biomarkers, regenerative periodontology, and molecular pathology, nurturing future dentists and researchers through an integrative, evidence-based curriculum and global research exposure.

💼 Experience:

Prof. Dr. Gültekin has over 25 years of experience in dentistry, oral pathology, and periodontology. She has served as Professor and Chair of the Department of Oral Pathology at Gazi University, shaping both academic curricula and national diagnostic standards. Internationally, she collaborated with UCSF and the University of Cologne on pioneering projects in oral cancer and HPV research. Her clinical and academic background spans over 50 funded research projects, with 96 published papers in prestigious journals indexed by SCI, Scopus, and PubMed. She has contributed to oral health policy through editorial and advisory roles, including at journals like Journal of Oral Health Frontiers. Her expertise has guided scientific boards and symposia in Türkiye and beyond, particularly in head and neck pathology. She remains a sought-after consultant and reviewer, advocating for personalized medicine and molecular diagnostics in oral health.

🔬 Research Focus:

Prof. Dr. Sibel Elif Gültekin’s research centers on the molecular mechanisms of oral diseases, particularly odontogenic tumors, oral epithelial dysplasia, and HPV-induced carcinomas. She has made key contributions in identifying biomarkers such as P16, PDCD4, VIM3, and CD8+ T-cell infiltrates, enhancing early diagnosis and prognosis of oral and oropharyngeal cancers. Her research also explores microsatellite instability and loss of heterozygosity in oral squamous cell carcinoma. Additionally, she has contributed to periodontal tissue regeneration studies and the development of personalized therapeutic strategies. With over 1,300 citations and an h-index of 17 on Google Scholar, her impactful work bridges molecular science and clinical application. Collaborating with global experts in pathology, oncology, and molecular biology, Prof. Gültekin’s research not only contributes to academic literature but also informs clinical protocols and treatment pathways in modern dentistry and oral oncology.

📚 Publications Top Notes:

  • 🧬 Microsatellite Instability and Loss of Heterozygosity as Prognostic Markers in Oral Squamous Cell Carcinoma (Genes, Chromosomes and Cancer, 2024)

  • 🧪 Efficiency of B-RAF-/MEK-inhibitors in B-RAF Mutated Ameloblastoma: Case Report and Review (Heliyon, 2023)

  • 🦷 Kişiselleştirilmiş Diş Hekimliği (ADO Klinik Bilimler Dergisi, 2023)

  • 🔍 Apoptosis Related PDCD4: Promising Novel Biomarker for Early Detection of Oral Cancer (ADO Klinik Bilimler Dergisi, 2022)

  • 🛡️ PD-L1 Expression and High CD8+ Lymphocyte Infiltrate Predict Outcome in Oropharyngeal SCC (International Journal of Molecular Sciences, 2020)

🧾 Conclusion:

Prof. Dr. Sibel Elif Gültekin is a highly deserving nominee for the Best Researcher Award. Her pioneering contributions in oral pathology, particularly in molecular diagnostics and HPV-related oral oncology, place her at the forefront of dental research. Her exceptional academic record, leadership, and dedication to collaborative and translational science make her a standout candidate who embodies the spirit of innovation, mentorship, and global impact.